During the past decade, University Hospital Southampton NHS Foundation Trust; Southampton Eye Unit conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University Hospital Southampton NHS Foundation Trust; Southampton Eye Unit" are "Diabetic Macular Edema" (2 trials) and "Neovascular Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "University Hospital Southampton NHS Foundation Trust; Southampton Eye Unit" in a lesser frequency.

Most popular intervention types in "University Hospital Southampton NHS Foundation Trust; Southampton Eye Unit" are "Drug" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (3 trials), "Sham Procedure" (3 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Southampton NHS Foundation Trust; Southampton Eye Unit" are 3 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Southampton NHS Foundation Trust; Southampton Eye Unit". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University Hospital Southampton NHS Foundation Trust; Southampton Eye Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Southampton NHS Foundation Trust; Southampton Eye Unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".